Kret Zaina, Akinola Oluwatosin Mautin, Ahlidja Wisdom, Joe Bina
Microbiome Consortium, Department of Physiology and Pharmacology, Center for Hypertension and Precision Medicine, University of Toledo College of Medicine and Life Sciences, OH.
Hypertension. 2025 Oct;82(10):1569-1589. doi: 10.1161/HYPERTENSIONAHA.125.17950. Epub 2025 Aug 20.
Hypertension is the single largest modifiable risk factor for chronic cardiovascular and renal diseases and strokes. Approximately 47% of American adults have hypertension. Despite the existence of pharmacological treatments, we remain highly vulnerable to the incidence of hypertension. Research in the past decade has identified microbiota as a previously unrecognized factor that regulates blood pressure. Because microbiota depends on the host food for its sustenance, diet presents as a potential factor to remodel microbiota composition and, thereby, affect blood pressure. Here, we survey the dietary sources of the 6 major food components: carbohydrates, proteins, fats, minerals, vitamins, and water for their ability to influence gut microbiota-mediated blood pressure regulation. Furthermore, beyond food components per se, we discuss how food additives and chemicals used in current agricultural practices could adversely remodel gut microbiota composition and contribute to hypertension. The goal of our work here is 2-prong: (1) to better understand why certain dietary components are beneficial over others for hypertensives because of their ability to remodel gut microbiota composition and (2) to advocate for further research and implementations of dietary interventions in the treatment of hypertension based on their ability to modulate gut microbiota.
高血压是慢性心血管疾病、肾脏疾病和中风唯一最大的可改变风险因素。约47%的美国成年人患有高血压。尽管存在药物治疗,但我们仍然极易患高血压。过去十年的研究已确定微生物群是一个此前未被认识的调节血压的因素。由于微生物群依赖宿主食物生存,饮食成为重塑微生物群组成从而影响血压的一个潜在因素。在此,我们调查6种主要食物成分(碳水化合物、蛋白质、脂肪、矿物质、维生素和水)的饮食来源影响肠道微生物群介导的血压调节的能力。此外,除了食物成分本身,我们还讨论了当前农业实践中使用的食品添加剂和化学物质如何不利地重塑肠道微生物群组成并导致高血压。我们此项工作的目标有两个方面:(1)更好地理解为何某些饮食成分因其重塑肠道微生物群组成的能力而对高血压患者比其他成分更有益;(2)基于饮食干预调节肠道微生物群的能力,倡导在高血压治疗中进一步开展相关研究并实施饮食干预措施。